In vitro activity of tigecycline against patient isolates collected during phase 3 clinical trials for hospital acquired pneumonia

The in vitro activity of tigecycline was evaluated against 819 baseline pathogens isolated from 383 patients enrolled in the phase 3 clinical trial investigating the efficacy of tigecycline in hospital acquired pneumonia (HAP). The trials were global, enrolling patients in 27 countries. Tigecycline...

Descripción completa

Detalles Bibliográficos
Autores principales: Petersen, Peter J., Tuckman, Margareta, Jones, C. Hal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892572/
https://www.ncbi.nlm.nih.gov/pubmed/24470884
http://dx.doi.org/10.4081/idr.2010.e1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892572/
https://www.ncbi.nlm.nih.gov/pubmed/24470884
http://dx.doi.org/10.4081/idr.2010.e1

Ejemplares similares